You are here
Neurologist. Clinical chief Neurology/Neuroimmunology Department
- President of the Executive Board of The European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS)
- Co-editor for Multiple Sclerosis Journal-ETC
- Member of the Health Care Ethics Committee, Vall d'Hebron University Hospital
- Member of the Health Care Ethics Committee, Spanish Society of Neurology (SEN)
- Medicine and Surgery, Universitat Autònoma de Barcelona
- Phd in Medicine, Universitat Autònoma de Barcelona
- Doctoral thesis: Antibodies endotelial anti-cell in patients with Multiple Sclerosis
- Neurology residency
Mar Tintoré M.D., PhD, is Professor of Neurology at the University of Vic – Catalonia’s Central University and the Clinical Coordinator of Neurology in the Neurology-Neuroimmunology Department at the Multiple Sclerosis (MS) Centre of Catalonia (Cemcat) at the Vall d'Hebron University Hospital in Barcelona, Spain. From June 2023 is the Head of Section of Neurology at the Multiple Sclerosis (MS) Centre of Catalonia (Cemcat) at the Vall d'Hebron University Hospital.
She also serves on the Clinical Ethics Committee of Vall d'Hebron University Hospital. Dr. Tintoré is the current President of the Executive Board of ECTRIMS "European Committee for Treatment and Research in Multiple Sclerosis”.
Dr. Tintoré’s research interests include the initial presentation and diagnostic criteria of demyelinating events, prognostic factors of MS, patient related outcomes and personalized medicine. Professor Tintoré’s research has also included longitudinal cohort studies characterizing gender aspects of MS such as pregnancy, and pediatric onset MS.
Projects / Lines of Research / Interests
Dra. Mar Tintore has developed studies about prognostic factors in MS and dynamic models for predicting prognosis in CIS patients. Her other main areas of interest are the study of gender-related factors, the development of diagnostic criteria and pediatric MS.
Dr. Tintoré has authored or co-authored over 260 articles in peer-reviewed journals and has an h-index of 60 as of May 2023, and its work has received 15,464 citations.